Laurus Labs Limited (LAURUSLABS) — Announcement | 10 August 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Laurus Labs receives ESG Score of 63 from NSE Sustainability Ratings
💡 Investor Takeaway
The ESG score reflects Laurus Labs' sustainability performance but does not impact financial results or future guidance.

Laurus Labs Limited announced that NSE Sustainability Ratings and Analytics independently assigned an ESG Score of 63 out of 100 for FY 2026, based on publicly available data without prior engagement. This disclosure complies with SEBI Listing Regulations and is for record-keeping purposes.

📄 View Original Announcement (PDF)

About Laurus Labs Limited (LAURUSLABS)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹1,00,486.42 Cr P/E: 91.8 ROE: 20.6% ROCE: 20.8% Div Yield: 0.06%

View full LAURUSLABS stock details →

📡 Get AI alerts when LAURUSLABS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LAURUSLABS — Free

📊 More LAURUSLABS filings

See all LAURUSLABS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LAURUSLABS files new disclosures

Track LAURUSLABS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track LAURUSLABS — Free

Free account · 2 AI queries/day